Teleflex (TFX) (BCR) (MDAS) (BDX) (MDR) (CAM) Price Targets Changed

Teleflex Incorporated (NYSE: TFX), C.R. Bard, Inc. (NYSE: BCR), MedAssets, Inc. (NASDAQ: MDAS), Becton Dickinson And Co (NYSE: BDX), McDermott International (NYSE: MDR) and Cameron (NYSE: CAM) price targets adjusted by analysts.

Teleflex Incorporated (TFX) had its price target lowered by Morgan Keegan from $65.00 to $58.00. They have a “Market Perform” rating on the company.

C.R. Bard, Inc. (BCR) had its price target lowered by Morgan Keegan from $115.00 to $107.00. They have an “Outperform” rating on the company.

MedAssets, Inc. (MDAS) had its price target lowered by Auriga from $21.00 to $19.00. They have a “Buy” rating on the company.

Becton Dickinson And Co. (BDX) had its price target lowered by Morgan Keegan from $90.00 to $86.00. They have a “Market Perform” rating on the company.

McDermott International (MDR) had its price target lowered by Morgan Keegan from $29.00 to $24.00. They have an “Outperform” rating on the company.

Cameron (CAM) had its price target lowered by Morgan Keegan from $68.00 to $61.00. They have an “Outperform” rating on the company.

MedAssets (MDAS) (HUM) (SNCR) (DLR) (FRO) (ARIA) (ALGT) (CPLP) (GEVO) Price Targets Changed

MedAssets, Inc. (NASDAQ: MDAS), Humana (NYSE: HUM), Synchronoss Technologies, Inc. (NASDAQ: SNCR), Digital Realty Trust, Inc. (NYSE: DLR), Frontline Ltd. (NYSE: FRO), Ariad Pharmaceutical (NASDAQ: ARIA), Allegiant Travel (NASDAQ: ALGT), Capital Product Partners L.P. (NASDAQ: CPLP) and Gevo, Inc. (NASDAQ: GEVO) price targets adjusted by analysts.

MedAssets, Inc. (MDAS) had its price target lowered by UBS AG (NYSE:UBS) from $15.50 to $13.00. The have a “Neutral” rating on the company.

Humana (NYSE: HUM) had its price target raised by Barclays Capital from $85.00 to $90.00. They have an “Equal Weight” rating on the company.

Synchronoss Technologies, Inc. (SNCR) had its price target raised by Stifel Nicolaus from $38.00 to $44.00. They have a “Buy” rating on the company.

Digital Realty Trust, Inc. (DLR) had its price target lowered by Barclays Capital from $70.00 to $67.00. They have an “Overweight” rating on the company.

Frontline Ltd. (FRO) had its price target lowered by Deutsche Bank (NYSE:DB) from $22.00 to $16.00. They have a “Buy” rating on the company.

Ariad Pharmaceutical (ARIA) had its price target raised by Brean Murray from $11.00 to $15.00. They have a “Buy” rating on the company.

Allegiant Travel (ALGT) had its price target cut by Barclays Capital from $65.00 to $61.00. They have an “Overweight” rating on the company.

Capital Product Partners L.P. (CPLP) had its price target lowered by Deutsche Bank from $9.00 to $8.00. They have a “Hold” rating on the company.

Gevo, Inc. (GEVO) had its price target boosted by UBS AG from $21.00 to $23.00. They have a “Buy” rating on the company.

Coverage on (INTC) (MDAS) (PCG) (PHH) (PMC) Initiated by Analysts

Intel Corporation (NASDAQ:INTC), MedAssets, INC. (NASDAQ:MDAS), PG&E Corp. (NYSE:PCG), PHH CORPORATION (NYSE:PHH) and PharMerica Corporation (NYSE:PMC) had coverage initiated on them by analysts.

Deutsche Bank (NYSE:DB) initiated coverage on Intel Corporation (INTC), starting them off with a "Buy" rating. They placed a price target of $27 on the company.

Deutsche Bank initiated coverage on MedAssets, INC. (MDAS), starting them off with a "Hold" rating. They raised their price target from $17.50 to $18 on the company.

Deutsche Bank initiated coverage on PG&E Corp. (PCG), starting them off with a "Hold" rating. They lowered their price target from $49 to $45 on the company.

FBR Capital Markets initiated coverage on PHH CORPORATION (PHH), starting them off with an "Outperform" rating. They placed a price target of $28 on the company.

Credit Suisse (NYSE:CS) initiated coverage on PharMerica Corporation (PMC), starting them off with a "Neutral" rating. They raised their price target from $11 to $12 on the company.

Ratings on (GNK) (ICE) (IN) (MDAS) (MET) Reiterated by Analysts

Ratings on Genco Shipping & Trading Ltd (NYSE: GNK), IntercontinentalExchange (NYSE: ICE), Intermec Inc. (NYSE: IN), MedAssets, Inc. (NASDAQ: MDAS) and MetLife, Inc. (NYSE: MET) were reiterated by analysts today.

Deutsche Bank (NYSE:DB) reiterated a “hold” rating on Genco Shipping & Trading Ltd (GNK). They have a price target of $8.00 on the company.

Jefferies (NYSE:JEF) reiterated a “hold” rating on IntercontinentalExchange (ICE). They have a price target of $130.00 on the company.

Morgan Keegan reiterated an “outperform” rating on Intermec Inc. (IN). They have a price target of $13.50 on the company.

Oppenheimer reiterated an “outperform” rating on MedAssets, Inc. (MDAS). They have a price target of $21.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated an “outperform” rating on MetLife, Inc. (MET). They have a price target $51.00 on the company.

MedAssets (MDAS) (MDRX) (QSII) (SOHU) (VICL) - New Ratings and Price Targets

New ratings and price targets on MedAssets, Inc. (NASDAQ: MDAS), Allscripts Healthcare Solutions (NASDAQ: MDRX), Quality Systems Inc (NASDAQ: QSII), Sohu.Com Inc. (NASDAQ: SOHU) and Vical Incorporated (NASDAQ: VICL).

Oppenheimer initiated coverage on MedAssets, Inc. (MDAS). They placed an “Outperform” rating and a price target of $21.00 on the company.

Oppenheimer initiated coverage on Allscripts Healthcare Solutions (MDRX). They placed an “Outperform” rating and a price target of $25.00 on the firm.

Oppenheimer initiated coverage on Quality Systems Inc (QSII). They placed a “Perform” rating on the stock.

Brean Murray initiated coverage on Sohu.Com Inc. (SOHU). They placed a “Hhold” rating on the shares.

Canaccord Genuity initiated coverage on Vical Incorporated (VICL). They placed a “buy” rating on the company.

NutriSystem (NTRI), Novatel Wireless, (NVTL) MedAssets, (MDAS) Crushed on Weak Guidance, Performance

NutriSystem (NASDAQ:NTRI), Novatel Wireless, (NASDAQ:NVTL) MedAssets and (NASDAQ:MDAS) were all getting hammered on weak guidance and/or performance.

Guidance continues to be the story this earnings season, as companies with great last quarters are punished if they hint that's not going to be the case going forward.

Novatel Wireless (NVTL) was 16.8% lower after hours; reporting a fourth quarter adj-EPS of breakeven, $0.01 lower than the analyst estimate of $0.01. Revenue for the quarter was at $119.3 million versus the consensus estimate of $114.68 million. Guidance was for first quarter adj-loss of 36-48 cents, vs. the consensus of a 4 cents gain. Sales are expected to reach $60-$80 million, vs. the Street estimate of $103.8 million.

NutriSystem (NTRI) dropped by 28.3% after hours, reporting fourth quarter EPS of $0.25, level with the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $100.64 million. Guidance if for a first quarter loss of $0.30-$0.35, versus the consensus of $0.30 profit. The company sees a full year 2011 profit of $0.40-$0.50, versus the consensus of $1.14.

MedAssets (MDAS) fell 16% after reporting fourth quarter EPS of $0.18, $0.04 lower than the analyst estimate of $0.22. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $122.17 million.

More Clarity Needed on MedAssets (NASDAQ:MDAS) Says Jefferies

Jefferies says they like the positioning of MedAssets (NASDAQ:MDAS)in the healthcare sector, but more clarity is needed for them to escape being range bound.

"We continue to believe that MDAS is well positioned in the healthcare market with a focus on cost-savings and revenue cycle; however, with moving parts such as Broadlane and caution on revenue cycle transformation deals, we believe that the stock is range bound until more clarity emerges," said Jefferies.

EPS estimates for full year 2011 were raised from $1.03 to $1.16.

Overall, Jefferies believes MedAssets, which closed Wednesday at $19.33, gaining $0.78. or 4.23 percent, will have a better year in 2011 than they did in 2010. Jefferies has a price target on them of $22, raising it from $20.